04/02/2024
4:00 PM | AbbVie (Issuer)
RAPP EDWARD J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
4:00 PM | AbbVie (Issuer)
Alpern Robert J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
4:00 PM | AbbVie (Issuer)
Quaggin Susan E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2024
1:31 PM | AbbVie (Subject)
Chevedden John (Filed by)
| Form PX14A6G | |
03/22/2024
4:00 PM | AbbVie (Issuer)
Donoghoe Nicholas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
1:29 PM | AbbVie (Subject)
Donoghoe Nicholas (Reporting)
| Form 144/A | |
03/20/2024
6:30 PM | AbbVie (Subject)
Donoghoe Nicholas (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
03/20/2024
4:00 PM | AbbVie (Issuer)
Stewart Jeffrey Ryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2024
3:27 PM | AbbVie (Filer)
| Form ARS | |
03/05/2024
4:30 PM | AbbVie (Issuer)
RICHMOND TIMOTHY J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
6:53 PM | AbbVie (Subject)
Reents Scott T (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024
4:50 PM | AbbVie (Issuer)
GONZALEZ RICHARD A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
4:50 PM | AbbVie (Issuer)
Donoghoe Nicholas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
4:50 PM | AbbVie (Issuer)
Thakkar Roopal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
4:50 PM | AbbVie (Issuer)
Hudson Thomas J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
4:50 PM | AbbVie (Issuer)
RICHMOND TIMOTHY J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
4:50 PM | AbbVie (Issuer)
SALEKI-GERHARDT AZITA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
4:50 PM | AbbVie (Issuer)
Stewart Jeffrey Ryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
4:50 PM | AbbVie (Issuer)
Siatis Perry C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
4:50 PM | AbbVie (Issuer)
Michael Robert A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
4:50 PM | AbbVie (Issuer)
Buckbee Kevin K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
4:50 PM | AbbVie (Issuer)
Reents Scott T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
3:20 PM | AbbVie (Subject)
RICHMOND TIMOTHY J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024
5:06 PM | AbbVie (Subject)
Buckbee Kevin K (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024
4:33 PM | AbbVie (Subject)
Michael Robert A. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024
4:00 PM | AbbVie (Issuer)
GONZALEZ RICHARD A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
4:52 PM | AbbVie (Subject)
GONZALEZ RICHARD A (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024
5:12 AM | AbbVie (Filer)
| Form 424B5 | |
02/23/2024
4:00 PM | AbbVie (Issuer)
SALEKI-GERHARDT AZITA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
8:14 PM | AbbVie (Subject)
| Form FWP | |
02/21/2024
5:00 PM | AbbVie (Subject)
SALEKI-GERHARDT AZITA (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2024
7:39 AM | AbbVie (Filer)
| Form 424B5 | |
02/20/2024
4:23 PM | AbbVie (Issuer)
SALEKI-GERHARDT AZITA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2024
11:45 AM | AbbVie (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/20/2024
8:00 AM | AbbVie (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/12/2024
6:49 AM | AbbVie (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/06/2024
4:00 PM | AbbVie (Issuer)
Siatis Perry C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
4:50 PM | AbbVie (Subject)
Siatis Perry C (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/02/2024
6:51 AM | AbbVie (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/25/2024
3:59 PM | AbbVie (Subject)
BlackRock Inc. (Filed by)
| Form SC 13G/A | |
01/03/2024
4:17 PM | AbbVie (Issuer)
Quaggin Susan E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Nerd Investor Reveals Secret To Make Money With A.I. (Ad) He's doing something he's never done before.
In ten years, this nerd investor has picked 210+ stocks that have gone up at least 100%. >>Check out what this A.I. Perfect Storm is<< |
01/03/2024
4:08 PM | AbbVie (Issuer)
Alpern Robert J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2023
4:00 PM | AbbVie (Issuer)
Donoghoe Nicholas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2023
4:02 PM | AbbVie (Subject)
Donoghoe Nicholas (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/06/2023
4:28 PM | AbbVie (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/30/2023
7:47 AM | AbbVie (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/15/2023
12:32 PM | AbbVie (Subject)
NEW YORK STOCK EXCHANGE LLC (Filed by)
| Form 25-NSE | |
11/06/2023
12:01 PM | AbbVie (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/27/2023
6:49 AM | AbbVie (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/19/2023
4:04 PM | AbbVie (Issuer)
Quaggin Susan E (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/19/2023
4:06 PM | AbbVie (Issuer)
Davis Jennifer L. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/12/2023
4:17 PM | AbbVie (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2023
3:11 PM | AbbVie (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/27/2023
4:00 PM | AbbVie (Issuer)
GONZALEZ RICHARD A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2023
4:00 PM | AbbVie (Issuer)
Alpern Robert J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/31/2023
3:01 PM | AbbVie (Subject)
GONZALEZ RICHARD A (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/31/2023
3:04 PM | AbbVie (Subject)
GONZALEZ RICHARD A (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/27/2023
6:45 AM | AbbVie (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/10/2023
4:04 PM | AbbVie (Issuer)
Donoghoe Nicholas (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/06/2023
3:18 PM | AbbVie (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/29/2023
4:00 PM | AbbVie (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/28/2023
4:00 PM | AbbVie (Filer)
| Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d) | |
05/05/2023
11:54 AM | AbbVie (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/04/2023
7:08 AM | AbbVie (Subject)
ZEVIN ASSET MANAGEMENT LLC (Filed by)
| Form PX14A6G | |
04/27/2023
4:00 PM | AbbVie (Issuer)
Sorg Elaine K. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/27/2023
6:36 AM | AbbVie (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/25/2023
3:16 PM | AbbVie (Subject)
AbbVie (Subject)
Sorg Elaine K. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/20/2023
2:39 PM | AbbVie (Subject)
Chevedden John (Filed by)
| Form PX14A6G | |
04/17/2023
4:42 PM | AbbVie (Subject)
Sorg Elaine K. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
